2011

Articles

• 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, Martini A, Rabinovich CE, Ruperto N. Arthritis Care & Research 2011 Vol. 63, No. 4, April 2011, pp 465–482 doi: 10.1002/acr.20460. PMID: 21452260
   
• Initial evaluation of an ultrasound measure for assessing the activity of skin lesions in juvenile localized scleroderma. Li SC, Liebling MS, Haines KA, Weiss JE, Prann A.. Arthritis Care Res (Hoboken) 2011 May;63(5):735-42. doi: 10.1002/acr.20407 PMID: 21557528
   
• American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Wallace CA, Giannini EH, Huang B, Itert L, Ruperto N; Childhood Arthritis Rheumatology Research Alliance; Pediatric Rheumatology Collaborative Study Group; Paediatric Rheumatology International Trials Organisation. Arthritis Care & Research 2011 Vol. 63, No. 7, July 2011, pp 929–936, doi: 10.1002/acr.20497. PMID: 21717596
   
• Extended report: Efficacy of intravenous IG therapy in juvenile dermatomyositis. Lam CG, Manlhiot C, Pullenayegum EM, Feldman BM. Ann Rheum Dis 2011 70:12 2089-2094. Published Online First: 6 October 2011. doi:10.1136/ard.2011.153718

Abstracts

• Clinical characteristics of children with juvenile dermatomyositis recruited within the first 7 months of the CARRAnet registry. Mark F Hoeltzel, Mara L Becker, Angela B Robinson, Brian M Feldman, Adam Huber, and Ann M Reed, Juvenile Myositis CARRA Subgroup , CARRAnet Investigators. Pediatr Rheumatol Online J 2012 10(Suppl 1): A12. Published online 2012 Jul 13. doi: 10.1186/1546-0096-10-S1-A12
   
• Disease characteristics and medication use in a multicenter cohort of children with juvenile idiopathic arthritis (JIA): preliminary analyses from the CARRAnet registry. Sarah Ringold*, Timothy Beukelman , Esi M Morgan DeWitt , Marc Natter , Peter A Nigrovic , Yukiko Kimura , CARRAnet Investigators. Ringold et al.. Pediatric Rheumatology 2011 10(Suppl 1):A46 http://www.ped-rheum.com/content/10/S1/A46
   
• Disease Modifying Anti-Rheumatic Drug Use in the Treatment of Juvenile Idiopathic Arthritis: A Cross-Sectional Analysis of the CARRA Registry. Beukelman T, Ringold S, Davis TE, DeWitt EM, Pelajo CF, Weiss PF, Kimura Y. CARRA Registry Investigators. J Rheumatol 2012 Sep;39(9):1867-74. Epub 2012 Aug 1
   
• Race is a risk factor for calcinosis in patients with JDM – early results from the CARRAnet registry study. Mark F Hoeltzel, Mara L Becker, Angela B Robinson, Brian M Feldman, Adam Huber, and Ann M Reed, Juvenile Myositis CARRA Subgroup , CARRAnet Investigators. Pediatr Rheumatol Online J 2012 10(Suppl 1): A65. Published online 2012 Jul 13. doi: 10.1186/1546-0096-10-S1-A65
   
• The childhood arthritis & rheumatology research alliance network registry: demographics and characteristics of the initial 6-month cohort. Marc D Natter, Jane R Winsor, Kathleen A Fox, Norman T Ilowite, Kenneth D Mandl, Kelly L Mieszkalski, Christy I Sandborg, John S Sundy, Carol A Wallace, and Laura E Schanberg, CARRAnet Investigators Group. Pediatr Rheumatol Online J 2012 10(Suppl 1): A57. Published online 2012 Jul 13. doi: 10.1186/1546-0096-10-S1-A57